AMC Cancer Institute

Why should you receive treatment at AMC Cancer Institute?

In 2006, AMC established Korea’s first multidisciplinary cancer institute, initiating its comprehensive approach to cancer treatment. A multidisciplinary clinic is a medical service where multiple specialists from diverse departments gather to provide customized treatment for a cancer patient from diagnosis to surgery. At AMC Cancer Institute, specialists in diagnostic, surgical, medical, and radiation oncology collaborate to develop individualized care plans for each patient.

The Institute has 16 sub-centers that are disease-specific and provides customized cancer treatment through its Center for Personalized Cancer Medicine.

Cancer Institute has conducted the largest number of cancer surgeries in Korea and has the highest survival rate.

16 Sub-Centers

• Liver Cancer Center
• Breast Cancer Center
• Head & Neck Cancer Center
• Brain Tumor Center
• Urologic Cancer Center
• Biliary & Pancreatic Cancer Center
• Skin Cancer Center
• Stomach Cancer Center
• Hematologic Cancer & BMT Center
• Lung Cancer Center
• Esophageal Cancer Center
• Sarcoma & Rare Cancer Center
• Colon Cancer Center
• Gynecologic Cancer Center
• Center for Personalized Cancer Medicine
• CAR T-Cell Therapy Center

Treatment Performance (2022)

The total number of cancer patients visiting AMC Cancer Institute recorded more than 1 million for the past three consecutive years, with 1,120,108 in 2022, 1,102,350 in 2021, and 1,037,050 in 2020. The number of multidisciplinary clinics increased from 5,472 cases in 2021 to 6,189 in 2022, marking an increase of 13%.

Achievements

• World’s largest number of gastric cancer cases treated
• World’s largest number of cervical cancer laparoscopic surgeries conducted
• Korea’s largest number of cancer surgeries conducted annually (especially liver cancer, pancreatic and biliary cancer, colon cancer, and breast cancer)
• Korea’s first multidisciplinary cancer center (2006)
• Korea’s first personalized cancer medicine center (2012)
• Korea’s first precision medicine platform (2020)
• Approximately 30% of face-to-face multidisciplinary integrated treatment in Korea (2020)
• 500 cases of esophageal cancer robotic surgery (the most significant number in Asia) (2021)
• Over 1 million cancer patients (2020-2022)